AI Product
EFAST low-EF detection
Digital stethoscopes and AI algorithms (SENSORA platform) for detecting cardiac murmurs, atrial fibrillation, and low ejection fraction, including EFAST low-EF detection.
- Status
- Active
- Category
- Healthcare AI product
- Developer
- Eko Health
- Industry
- AI in Healthcare
- Country
- United States
- Deployment
- The company progressed through FDA clearance pathways for…
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
Eko Health introduced EFAST low-EF detection to deliver targeted intelligence capabilities for technical teams, data leaders, and operational specialists in Healthcare. The system automates correlating genomic sequencing profiles against clinical outcome registries, directly counteracting the friction caused by inconsistent pathological classification and clinical documentation burden.
Emeryville digital stethoscope company combining hardware sensors with AI cardiac detection
What it does
Digital stethoscopes and AI algorithms (SENSORA platform) for detecting cardiac murmurs, atrial fibrillation, and low ejection fraction, including EFAST low-EF detection.
Who develops it
Primary care physicians, cardiologists, and health systems screening for heart disease in outpatient and telehealth settings.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- Digital stethoscopes and AI algorithms (SENSORA platform) for detecting cardiac murmurs, atrial fibrillation, and low eje
- EFAST low-EF detection
Technology & Architecture
Technologies, models, and technical structure linked to this product.
Use Cases
Where this product is applied in real operational contexts.
- Digital stethoscopes and AI algorithms (SENSORA platform) for detecting cardiac murmurs, atrial fibrillation, and low ejection fraction, including EFAST low-EF detection.
- Medical Imaging: Automating multi-step verification to enhance outcome reliability.
- Clinical Documentation: Providing continuous real-time telemetry to operational leaders.
Who It Is For
Target users, industries, and deployment context.
Primary care physicians, cardiologists, and health systems screening for heart disease in outpatient and telehealth settings.
Industries
Industries served
- AI in Healthcare
- Medical Devices
Enterprise buyers and technical teams, data leaders, and operational specialists in Healthcare utilize EFAST low-EF detection across mission-critical workflows. Systems administrators can configure the platform within on-premises hospital data centers behind zero-trust firewalls.
Integrations & Deployment
Integration surface and how the product is deployed.
Deployment: The company progressed through FDA clearance pathways for…
Enterprises can integrate EFAST low-EF detection into existing operational stacks via modular connectors, secure webhooks, and programmatic SDKs. This ensures cohesive synchronization between the AI platform and downstream reporting systems.
Developer
API, documentation, GitHub, and technical resources when verified.
-
Official product https://www.ekohealth.com/blogs/newsroom/fda-clearance-efast-sensora
Developer / Company
The organization that builds and ships this product.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
What does EFAST low-EF detection offer?
EFAST low-EF detection is an AI solution developed by Eko Health, designed to deliver shortening experimental therapeutic discovery lifecycles by systematizing accelerating diagnostic evidence extraction and molecular modeling.
What company operates EFAST low-EF detection?
EFAST low-EF detection is built and maintained by Eko Health, based in Emeryville, United States.
What are the core technical features of EFAST low-EF detection?
Documented capabilities include: Digital stethoscopes and AI algorithms (SENSORA platform) for detecting cardiac murmurs, atrial fibrillation, and low eje EFAST low; Eko's AI models analyze heart sound patterns and associated ECG signals to classify murmurs and rhythm abnormalities, with EFAST extending detection to low ejection fraction — a condition traditionally requiring echocardiography; FDA clearance for EFAST, documented in Eko's newsroom, indicates the algorithm met agency thresholds for clinical decision support in this indication.
What machine learning stack powers EFAST low-EF detection?
EFAST low-EF detection utilizes Machine Learning, Deep Learning, Predictive Analytics, Healthcare Analytics, supporting deployment across on-premises hospital data centers behind zero-trust firewalls.
Who is EFAST low-EF detection intended for?
The software is engineered for Primary care physicians, cardiologists, and health systems screening for heart disease in outpatient and telehealth settings. seeking to mitigate unstructured electronic health record (EHR) data silos.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.